| Theme | Role of Endoscopy in the Diagnosis and Treatments of Pancreatic Diseases | |
|---|---|---|
| Title | Evaluation of the Chemotherapy for the Unresectable Pancreatic Cancer | |
| Publish Date | 2008/07 | |
| Author | Shujiro Yazumi | Department of Gastroenterology and Hepatology, the Tazuke Kofukai Medical Research Institute Kitano Hospital / Department of Gastroenterology and Hepatology, Kyoto Unirersity Graduate School of Medicine |
| Author | Masashi Kanai | Outpatient Oncology Unit, Kyoto Unirersity Hospital |
| Author | Tadayuki Ko | Department of Gastroenterology and Hepatology, the Tazuke Kofukai Medical Research Institute Kitano Hospital |
| Author | Masanori Asada | Department of Gastroenterology and Hepatology, the Tazuke Kofukai Medical Research Institute Kitano Hospital |
| Author | Kenji Ueno | Department of Gastroenterology and Hepatology, Kyoto Unirersity Graduate School of Medicine |
| Author | Shinsuke Tada | Department of Gastroenterology and Hepatology, Kyoto Unirersity Graduate School of Medicine |
| [ Summary ] | To evaluate the efficacy of chemotherapy for solid tumors, the RECIST guidelines are usually adopted. In pancreatic cancer cases, however, there are several situations in which the RECIST guidelines cannot properly evaluate the following ; 1) situations where contrast enhanced CTs cannot detect the tumor ; 2) cases where contrast enhanced CTs cannot clearly demonstrate the border of tumors, 3) those with duodenal invasion, and 4) peritoneal metastasis without ascites. Therefore, the continuation of chemotherapy must be decided on according to the individual clinical status of patients with advanced pancreatic cancer. | |